Federated Hermes
CRBU icon

Federated Hermes’s Caribou Biosciences CRBU Stock Holding History

Federated Hermes’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.17K Hold
2,722
– – ﹤0.01% 1883
2025
Q4 		$4.33K Sell
2,722
-344
-11% -$722 ﹤0.01% 1904
2025
Q3 		$7.14K Sell
3,066
-4,851
-61% -$9.16K ﹤0.01% 1908
2025
Q2 		$9.97K Sell
7,917
-5,614
-41% -$5.52K ﹤0.01% 1817
2025
Q1 		$12.4K Buy
13,531
+10,769
+390% +$14K ﹤0.01% 1779
2024
Q4 		$4.39K Buy
+2,762
New +$5.55K ﹤0.01% 1907

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Federated Hermes's CRBU Position: Q1 2026 in Review

Federated Hermes held its Caribou Biosciences (CRBU) position steady in Q1 2026 at 2,722 shares worth $5.17K. The position accounts for ﹤0.01% of the portfolio, ranked #1883.

Federated Hermes first reported a position in CRBU in Q4 2024 and has held it in 6 quarters since. The position peaked at $12.4K in Q1 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Federated Hermes held 2,722 shares of Caribou Biosciences worth $5.17K as of Q1 2026.
  • Federated Hermes left its Caribou Biosciences share count unchanged in Q1 2026.
  • Caribou Biosciences made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1883 holding.
  • Federated Hermes first reported a position in Caribou Biosciences in Q4 2024 and has held it in 6 quarters since.
  • Federated Hermes's Caribou Biosciences position peaked at $12.4K in Q1 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.